Repligen
RGEN
#1859
Rank
โ‚น1.041 T
Marketcap
โ‚น16,290
Share price
2.97%
Change (1 day)
26.18%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): โ‚น172.53

According to Repligen 's latest financial reports the company's current EPS (TTM) is -โ‚น18.78. In 2022 the company made an earnings per share (EPS) of โ‚น315.49 an increase over its 2021 EPS that were of โ‚น219.71.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น172.53-45.31%
2022โ‚น315.4943.59%
2021โ‚น219.71105.26%
2020โ‚น107.04153.33%
2019โ‚น42.2518.42%
2018โ‚น35.68-47.95%
2017โ‚น68.54108.57%
2016โ‚น32.8620.69%
2015โ‚น27.2316%
2014โ‚น23.47-48.98%
2013โ‚น46.016.52%
2012โ‚น43.19-512.88%
2011-โ‚น10.46-1214.13%
2010โ‚น0.94-106.25%
2009-โ‚น15.02-200%
2008โ‚น15.02-87.79%
2007โ‚น123.00-2283.33%
2006-โ‚น5.63-300%
2005โ‚น2.82-115%
2004-โ‚น18.78-25.93%
2003-โ‚น25.3580%
2002-โ‚น14.08-21.05%
2001-โ‚น17.84-0%
2000-โ‚น17.84-17.39%
1999-โ‚น21.60245.01%
1998-โ‚น6.2633.33%
1997-โ‚น4.69-87.18%
1996-โ‚น36.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.36-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,783-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น819.70-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.41-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น35.68 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น142.72 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น661.96-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น109.86-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น35.68-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚น454.45 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA